MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease

Phase 2
Completed
Conditions
Anemia of Chronic Kidney Disease
Interventions
First Posted Date
2012-02-14
Last Posted Date
2017-06-14
Lead Sponsor
Johns Hopkins University
Target Recruit Count
34
Registration Number
NCT01532349
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases

Phase 3
Terminated
Conditions
Chronic Lymphoid Leukemia
Interventions
Drug: oleum neutralicum
Drug: Cholecalciferol
First Posted Date
2012-01-26
Last Posted Date
2020-07-16
Lead Sponsor
Semmelweis University
Target Recruit Count
31
Registration Number
NCT01518959
Locations
🇭🇺

Semmelweis University - 1st Departement of Internal Medicine, Budapest, Hungary

Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

Phase 2
Completed
Conditions
Muscle Pain
Joint Pain
Interventions
First Posted Date
2012-01-12
Last Posted Date
2019-06-18
Lead Sponsor
HealthPartners Institute
Target Recruit Count
116
Registration Number
NCT01509079
Locations
🇺🇸

Park Nicollet Frauenshuh Cancer Center, Minneapolis, Minnesota, United States

Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway

Phase 2
Terminated
Conditions
Neurotoxicity
Interventions
First Posted Date
2011-12-26
Last Posted Date
2021-11-10
Lead Sponsor
Gerald Higa, PharmD.
Target Recruit Count
9
Registration Number
NCT01499940
Locations
🇺🇸

West Virginia University Hospitals Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States

Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2

Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
Glucose Intolerance
Vitamin D Deficiency
Interventions
Drug: Placebo
Drug: Vitamin D3
First Posted Date
2011-12-22
Last Posted Date
2014-09-10
Lead Sponsor
Karolinska Institutet
Target Recruit Count
44
Registration Number
NCT01497132
Locations
🇸🇪

Dpt of Endocrinology, Karolinska University Hospital, Stockholm, Sweden

Muscle-Related Side Effects of Statins: Functional Impact, Mechanisms, and Potential Relief With Vitamin D Supplementation

Not Applicable
Completed
Conditions
HMG COA Reductase Inhibitor Adverse Reaction
Interventions
Drug: Placebo
Drug: Vitamin D
First Posted Date
2011-12-16
Last Posted Date
2016-01-27
Lead Sponsor
CHU de Quebec-Universite Laval
Target Recruit Count
78
Registration Number
NCT01493648
Locations
🇨🇦

Centre hospitalier universitaire de Québec - CHUL, Québec, Quebec, Canada

Vitamin D Supplementation in Multiple Sclerosis

Phase 3
Completed
Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
First Posted Date
2011-12-13
Last Posted Date
2022-09-28
Lead Sponsor
Johns Hopkins University
Target Recruit Count
172
Registration Number
NCT01490502
Locations
🇺🇸

Dignity Health Medical Foundation, Carmichael, California, United States

🇺🇸

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

and more 13 locations

Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D Levels

Phase 2
Conditions
Heart Failure
Vitamin D Deficiency
Interventions
First Posted Date
2011-11-23
Last Posted Date
2011-11-23
Lead Sponsor
Azienda Unita' Sanitaria Locale Di Modena
Target Recruit Count
34
Registration Number
NCT01477801
Locations
🇮🇹

Medicina Cardiovascolare - NOCSAE - Azienda USL, Modena, (mo), Italy

Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

Not Applicable
Completed
Conditions
Melanoma, Skin
Interventions
Drug: placebo and vitamin D
Drug: Vitamin D3
First Posted Date
2011-11-22
Last Posted Date
2016-12-23
Lead Sponsor
Stanford University
Target Recruit Count
24
Registration Number
NCT01477463
Locations
🇺🇸

Stanford University Cancer Institute, Palo Alto, California, United States

Vitamin D Supplementation in Diabetic Nephropathy

Phase 2
Completed
Conditions
Sub-optimal Vitamin D Status
Diabetic Nephropathy
Bone Disease
Interventions
First Posted Date
2011-11-22
Last Posted Date
2022-08-31
Lead Sponsor
University of Alberta
Target Recruit Count
120
Registration Number
NCT01476501
Locations
🇨🇦

Clinical Research Unit, University of Alberta, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath